BidaskClub upgraded shares of Walgreens Boots Alliance (NASDAQ:WBA) from a sell rating to a hold rating in a research note published on Friday.
WBA has been the subject of a number of other reports. ValuEngine cut shares of Walgreens Boots Alliance from a sell rating to a strong sell rating in a report on Tuesday, May 22nd. Pivotal Research set a $70.00 target price on shares of Walgreens Boots Alliance and gave the company a hold rating in a report on Thursday, March 29th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $71.00 target price for the company in a report on Saturday, April 7th. Jefferies Financial Group set a $85.00 target price on shares of Walgreens Boots Alliance and gave the company a buy rating in a report on Tuesday, April 3rd. Finally, Bank of America began coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, February 27th. They issued a neutral rating and a $76.00 price target for the company. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance currently has an average rating of Buy and an average target price of $81.95.
Walgreens Boots Alliance opened at $67.24 on Friday, according to MarketBeat. Walgreens Boots Alliance has a twelve month low of $61.56 and a twelve month high of $83.89. The company has a market cap of $67.05 billion, a PE ratio of 13.18, a P/E/G ratio of 1.09 and a beta of 1.14. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, beating the Zacks’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The business had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. During the same period in the prior year, the company earned $1.36 earnings per share. The firm’s revenue was up 12.1% on a year-over-year basis. research analysts predict that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 12th. Investors of record on Friday, May 18th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.38%. Walgreens Boots Alliance’s dividend payout ratio is 31.37%.
In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total transaction of $179,372.16. Following the completion of the transaction, the director now owns 13,679 shares in the company, valued at $896,795.24. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.80% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of WBA. Sei Investments Co. boosted its position in shares of Walgreens Boots Alliance by 31.2% during the fourth quarter. Sei Investments Co. now owns 143,188 shares of the pharmacy operator’s stock worth $10,398,000 after acquiring an additional 34,027 shares during the last quarter. Valeo Financial Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 45.0% during the fourth quarter. Valeo Financial Advisors LLC now owns 3,339 shares of the pharmacy operator’s stock worth $242,000 after acquiring an additional 1,036 shares during the last quarter. Trustcore Financial Services LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $155,000. Employees Retirement System of Texas boosted its position in shares of Walgreens Boots Alliance by 3.5% during the fourth quarter. Employees Retirement System of Texas now owns 263,000 shares of the pharmacy operator’s stock worth $19,099,000 after acquiring an additional 9,000 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of Walgreens Boots Alliance by 675.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,891,845 shares of the pharmacy operator’s stock worth $427,866,000 after acquiring an additional 5,132,140 shares during the last quarter. Hedge funds and other institutional investors own 60.25% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.